# Carb\-X Generated by Yoast SEO v28.7, this is an llms.txt file, meant for consumption by LLMs. ## Pages - [Careers](https://carb-x.org/about/careers/) - [Home](https://carb-x.org/) - [Portfolio Acceleration Tools](https://carb-x.org/portfolio/portfolio-acceleration-tools-overview/) - [Comprehensive Support](https://carb-x.org/portfolio/comprehensive-support/) - [Management \& Staff](https://carb-x.org/about/management-team/) ## Team - [KEVIN OUTTERSON, ESQ\.](https://carb-x.org/team/kevin-outterson-esq/) - [Francesca Bernardini, PhD](https://carb-x.org/team/francesca-bernadini-phd/) - [Gabrielle Gonzalez](https://carb-x.org/team/gabrielle-gonzalez/) - [Sarah Walker](https://carb-x.org/team/sarah-walker/) - [Peter Seiler, PhD](https://carb-x.org/team/peter-seiler-phd/) ## Gallery - [Centauri Therapeutics](https://carb-x.org/gallery/centauri-therapeutics/) - [Innoviva Specialty Therapeutics](https://carb-x.org/gallery/innoviva-specialty-therapeutics/) - [University of Maryland](https://carb-x.org/gallery/university-of-maryland/) - [AdJane](https://carb-x.org/gallery/10173/) - [Myers Research Group](https://carb-x.org/gallery/myers-research-group/) ## CARB\-X News - [The solution to AMR needs a multi\-pronged approach](https://carb-x.org/carb-x-news/the-solution-to-amr-needs-a-multi-pronged-approach/) - [Breaking the wall of deadly bacterial infections](https://carb-x.org/carb-x-news/breaking-the-wall-of-deadly-bacterial-infections/) - [One year on: Building EUP OHAMR together](https://carb-x.org/carb-x-news/one-year-on-building-eup-ohamr-together/) - [SNIPR enrolls first patient in Phase 2 portion of SNIPR001 trial, expanding study to 66 patients](https://carb-x.org/carb-x-news/snipr-enrolls-first-patient-in-phase-2-portion-of-snipr001-trial-expanding-study-to-66-patients/) - [Vaxdyn raises €11M Series A to test AMR vaccine](https://carb-x.org/carb-x-news/vaxdyn-raises-e11m-series-a-to-test-amr-vaccine/) ## Recommended News - [Solving Antimicrobial Resistance, Vaccines, Antibiotics](https://carb-x.org/recommended_news/solving-antimicrobial-resistance-vaccines-antibiotics/): Antibiotic\-resistant superbugs could become a greater threat than cancer\. Bruno and Pedro at the startup Immunethep explain how they’re tackling the crisis with vaccines\. - [Visby Medical CEO Explains What Makes its PCR Test for Women’s Health Different](https://carb-x.org/recommended_news/visby-medical-ceo-explains-what-makes-its-pcr-test-for-womens-health-different/): Visby Medical CEO explains what makes its PCR test for women’s health different - [What Is the Cost of Underinvesting in Health?](https://carb-x.org/recommended_news/what-is-the-cost-of-underinvesting-in-health/): Every $1 invested in health yields up to $4 in economic return, yet health systems remain chronically underfunded\. From antimicrobial resistance to air pollution, aid cuts and digital health gaps, the cost of inaction is mounting\. What are the societal and economic consequences of underinvesting in health and how do we begin to address them? - [Industry Innovation Series: Frontiers in Infectious Diseases Innovation](https://carb-x.org/recommended_news/industry-innovation-series-frontiers-in-infectious-diseases-innovation/): The final event in the 2025 Industry Innovation Series, ‘Frontiers in Infectious Diseases Innovation,’ offered attendees \- across industry and academia \- a unique opportunity to explore pioneering advances in infectious disease solutions and collaborative opportunities\. Hosted in La Trobe University’s innovation centre, Eagleworks, on the Melbourne Campus, it was an evening of insightful discussion and networking, and highlighted the critical role of innovation in shaping the future of disease prevention and treatment\. - [Leveraging Evidence and Tools to Advance AMR Policy Implementation](https://carb-x.org/recommended_news/leveraging-evidence-and-tools-to-advance-amr-policy-implementation/) ## Portfolio Acceleration Tools - [Superiority Clinical Trial Design Considerations](https://carb-x.org/portfolio-acceleration-tools/susceptibility-trials/) - [Susceptibility and Early Evaluation of Resistance Risks](https://carb-x.org/portfolio-acceleration-tools/susceptibility-and-early-evaluation-of-resistance-risks/) - [Predictive \& Translatable Nephrotoxicity Models](https://carb-x.org/portfolio-acceleration-tools/predictive-translatable-nephrotoxicity-models/) - [Antigen Conservation and Epidemiology](https://carb-x.org/portfolio-acceleration-tools/antigen-conservation-and-epidemiology/) - [Animal Models of Translation](https://carb-x.org/portfolio-acceleration-tools/animal-models-of-translation/) ## Venues - [London, UK](https://carb-x.org/venue/london-u-k/) - [Vienna, Austria](https://carb-x.org/venue/vienna-austria/) - [Basel, Switzerland](https://carb-x.org/venue/basel-switzerland/) - [London, UK](https://carb-x.org/venue/london-uk/) - [Tokyo, Japan](https://carb-x.org/venue/tokyo-japan/) ## Organizers - [GAMRIC](https://carb-x.org/organizer/gamric/) - [Financial Times](https://carb-x.org/organizer/financial-times/) - [McMaster University](https://carb-x.org/organizer/mcmaster-university/) - [British Society for Antimicrobial Chemotherapy](https://carb-x.org/organizer/british-society-for-antimicrobial-chemotherapy/) - [Les Pensières Center for Global Health](https://carb-x.org/organizer/les-pensieres-center-for-global-health/) ## Events - [Global AMR Innovators Conference \(GAMRIC\)](https://carb-x.org/event/global-amr-innovators-conference-gamric/) - [World Health Summit 2025](https://carb-x.org/event/world-health-summit-2025/) - [Association for Diagnostics \& Laboratory Medicine 2025](https://carb-x.org/event/association-for-diagnostics-laboratory-medicine-2025/) - [ASM Microbe](https://carb-x.org/event/asm-microbe-2/) - [The 2nd Asia Pacific Conference on Point of Care Testing for Infectious Diseases](https://carb-x.org/event/the-2nd-asia-pacific-conference-on-point-of-care-testing-for-infectious-diseases/) ## Optional - [Sitemap index](https://carb-x.org/sitemap_index.xml)